Pliant Therapeutics earnings were -$92.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest PLRX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$22.4M, up 11.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PLRX reported annual earnings of -$149.3M, with -29% growth. The next PLRX earnings date is Nov 5, 2026.
Pliant Therapeutics Earnings Reports & History FAQ
What were Pliant Therapeutics's earnings last quarter?
On PLRX's earnings call on Aug 13, 2026, Pliant Therapeutics (NASDAQ: PLRX) reported Q2 2026 earnings per share (EPS) of -$0.36, up 49.3% year over year. Total PLRX earnings for the quarter were -$22.37 million. In the same quarter last year, Pliant Therapeutics's earnings per share (EPS) was -$0.71.
The next PLRX earnings date is Nov 5, 2026. Add PLRX to your watchlist to be reminded of Pliant Therapeutics's next earnings date.
Is Pliant Therapeutics profitable or losing money?
As of the last Pliant Therapeutics earnings report, Pliant Therapeutics is currently losing money. Pliant Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$92.29 million, a 55.41% decrease year over year.
What was PLRX's earnings growth in the past year?
As of Pliant Therapeutics's earnings date in Aug 13, 2026, Pliant Therapeutics's earnings has grown year over year. PLRX earnings in the past year totalled -$92.29 million.
What are Pliant Therapeutics's earnings expectations?
The current EPS estimate for Pliant Therapeutics's earnings report in Nov 5, 2026 is -$0.37.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.